The Automated Daily - Top News Edition
Gene test to skip chemo & Hepatitis B drug functional cure - News (May 30, 2026)
Descripción
Please support this podcast by checking out our sponsors: - Discover the Future of AI Audio with ElevenLabs - https://try.elevenlabs.io/tad [https://try.elevenlabs.io/tad] - Effortless AI design for presentations, websites, and more with Gamma - https://try.gamma.app/tad [https://try.gamma.app/tad] - Lindy is your ultimate AI assistant that proactively manages your inbox - https://try.lindy.ai/tad [https://try.lindy.ai/tad] Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily [https://buymeacoffee.com/theautomateddaily] TODAY'S TOPICS: GENE TEST TO SKIP CHEMO - A MAJOR OPTIMA TRIAL SUGGESTS THE PROSIGNA GENOMIC TEST CAN IDENTIFY HORMONE-POSITIVE BREAST CANCER PATIENTS WHO CAN SAFELY AVOID CHEMOTHERAPY, CUTTING TOXIC SIDE EFFECTS WHILE KEEPING OUTCOMES STRONG. HEPATITIS B DRUG FUNCTIONAL CURE - TWO INTERNATIONAL TRIALS REPORT BEPIROVIRSEN HELPED SOME CHRONIC HEPATITIS B PATIENTS REACH A “FUNCTIONAL CURE,” WITH SUSTAINED REMISSION AFTER STOPPING THERAPY—AN IMPORTANT SHIFT FROM LIFELONG SUPPRESSION. NERVE REGROWTH IN HUMAN ORGANOIDS - CAMBRIDGE RESEARCHERS LINKED BRAIN AND SPINAL CORD ORGANOIDS TO SHOW WHY NERVE REPAIR FADES WITH MATURITY, AND HOW BLOCKING KEY GENE REGULATORS PLUS A KNOWN DRUG CANDIDATE MAY RESTORE AXON REGROWTH. NATO COMMAND EXPANSION IN BALTICS - GERMANY AND THE NETHERLANDS WILL STAND UP A NEW NATO TACTICAL HEADQUARTERS NEAR ESTONIA AND LATVIA, AIMED AT FASTER DECISIONS AND STRONGER DETERRENCE AGAINST RUSSIA ON THE EASTERN FLANK. CANADA TRIBUNAL ON INDIGENOUS GENOCIDE - THE PERMANENT PEOPLES’ TRIBUNAL ISSUED AN INTERIM RULING CALLING CANADA’S CURRENT POLICIES AN ONGOING GENOCIDE AGAINST INDIGENOUS PEOPLES, INTENSIFYING DEBATE OVER ACCOUNTABILITY, RESIDENTIAL SCHOOLS, AND REFORM. US TAKES STAKES IN QUANTUM FIRMS - UNDER THE CHIPS AND SCIENCE ACT, THE US COMMERCE DEPARTMENT PLANS MINORITY EQUITY STAKES IN QUANTUM COMPUTING FIRMS, SIGNALING A NEW “GOVERNMENT-AS-SHAREHOLDER” APPROACH THAT COULD CHANGE HOW MARKETS PRICE RISK. INDIA’S PLAN FOR CHIP INDEPENDENCE - A NITI AAYOG REPORT SAYS INDIA’S SEMICONDUCTOR MARKET COULD REACH AROUND $200 BILLION BY 2035, BUT WARNS HEAVY IMPORT DEPENDENCE AND CALLS FOR MAJOR INVESTMENT ACROSS FABS, PACKAGING, AND TALENT. AI MEMORY BOOM RESHAPES PRICING - MICRON AND SK HYNIX HITTING TRILLION-DOLLAR VALUATIONS ALONGSIDE SAMSUNG SHOWS HOW AI DEMAND FOR HBM MEMORY IS TIGHTENING SUPPLY—AND COULD PUSH UP PRICES FOR PHONES, PCS, AND OTHER DEVICES. NVIDIA BETS BIG ON PHOTONICS - NVIDIA IS POURING BILLIONS INTO SILICON PHOTONICS TO REDUCE THE POWER AND HEAT LIMITS OF COPPER CONNECTIONS IN AI DATA CENTERS, BETTING OPTICAL LINKS WILL BE ESSENTIAL FOR SCALING FUTURE “AI FACTORY” SYSTEMS. AI TOOLS HELP DISABLED MUSICIANS - A PARKINSON’S-DIAGNOSED SINGER-SONGWRITER USED GENERATIVE AI TOOLS TO CREATE WORKABLE DEMO ARRANGEMENTS, SPOTLIGHTING AI AS AN ACCESSIBILITY TOOL EVEN AS COPYRIGHT AND TRAINING-DATA DISPUTES CONTINUE. Episode Transcript Gene test to skip chemo In health news, an international breast cancer trial is pointing toward a future where far fewer patients have to endure chemotherapy after surgery. The Optima study, run by University College London and involving more than four thousand patients, used a genomic test called Prosigna to read activity across a set of tumor genes and estimate recurrence risk. Patients who scored low largely received hormone therapy alone, and their outcomes were almost the same as those who went through the standard chemo-plus-hormone approach. Five years out, the low-score group that skipped chemo was about as likely to be alive and recurrence-free as the group that got it. If this holds up in guidelines, it’s a big deal: it shifts decisions away from broad, one-size-fits-many clinical factors and toward the biology of an individual tumor—while sparing people the long and sometimes lasting side effects of chemotherapy. Hepatitis B drug functional cure Another medical update could change the long-term outlook for chronic hepatitis B, a disease that typically means taking medication indefinitely. Results from two international trials suggest an experimental drug, bepirovirsen, helped some patients reach what researchers call a “functional cure”—meaning they could stop treatment without the virus roaring back, at least over the follow-up so far. Roughly one in five participants who got weekly injections for six months, alongside standard daily antivirals, stayed undetectable for at least six months after stopping everything. Researchers stress that longer follow-up is essential, and the trials didn’t include everyone—people with certain higher-risk conditions were excluded. Still, even partial success is notable in a disease that contributes to liver failure and cancer worldwide. Nerve regrowth in human organoids Researchers at the University of Cambridge have also delivered a fascinating clue about why injuries to the brain and spinal cord are so often permanent. They built connected “organoids”—miniature lab-grown versions of brain and spinal cord tissue—so nerve fibers could grow between them and even trigger contractions in small muscle-cell clusters. The key finding: young, still-developing neural circuits could regrow damaged connections for a time, but that ability dropped sharply as the neurons matured, echoing what’s seen in adult patients. The team also flagged a gene-regulation network that seems to flip nerve growth “off” as the system develops. Blocking parts of that network helped more mature neurons regain some ability to extend fibers after injury. A drug screen highlighted lynestrenol, an already approved hormone medication, as a candidate that boosted regrowth in this model. It’s not a ready-made cure—real injuries involve scarring and inflammation, and reconnecting nerves correctly is a massive challenge—but it’s a step toward therapies tested in human-like systems rather than relying only on animal models. NATO command expansion in Baltics Turning to security in Europe, Germany and the Netherlands say they’ll set up a joint NATO tactical headquarters in the Baltic region later this year. The command, linked to the German–Netherlands Corps, is expected to take on responsibilities focused on the Estonia–Latvia area, adding another major command layer beyond the existing headquarters in Poland. The practical point is speed and capacity: more planning power, more exercises, and more ability to coordinate large forces quickly if the situation deteriorates. The move comes amid persistent anxiety about hybrid threats in the region—things like suspected sabotage of undersea infrastructure and increased drone-related incidents—alongside NATO’s continuing effort to deter Russia without stumbling into escalation. Canada tribunal on Indigenous genocide In Canada, a “court of opinion” known as the Permanent Peoples’ Tribunal issued an interim ruling concluding that Canada’s current policies amount to an ongoing genocide against Indigenous Peoples. The hearings in Montreal were requested by the Native Women’s Shelter of Montreal and focused on missing Indigenous children and unmarked graves associated with the residential school system, alongside testimony about forced family separation, cultural destruction, and abuse. The federal government did not take part in the proceedings, while saying publicly it continues work on reconciliation and responses to the Truth and Reconciliation Commission’s Calls to Action. The tribunal’s final decision is expected on September 30th—Canada’s National Day for Truth and Reconciliation—keeping pressure on debates over accountability, denial, and the pace of reform. US takes stakes in quantum firms In US tech policy, the Commerce Department has signed letters of intent to put about two billion dollars into quantum computing and related hardware firms under the CHIPS and Science Act—but with a twist that grabbed Wall Street’s attention. Instead of typical research grants, the government plans to take minority equity stakes. The biggest headline is a billion-dollar commitment tied to a newly formed IBM quantum subsidiary, with additional planned support for firms including GlobalFoundries, Rigetti, D-Wave, Quantinuum, and Diraq. Supporters say the approach can provide stability and credibility to a risky but strategically important field, while critics warn it looks like the government picking winners and shielding investors from downside. Either way, it signals a shift: Washington may increasingly fund frontier tech not just as a sponsor, but as a shareholder. India’s plan for chip independence In India, a new report from NITI Aayog projects the country’s semiconductor market could grow to around two hundred billion dollars by 2035, driven by domestic demand. The report also highlights the current vulnerability: India imports the vast majority of the chips it uses, which drains foreign currency and leaves key industries exposed when global supply chains seize up. The proposed fix is expensive and long-term—hundreds of billions in cumulative investment across design, manufacturing, advanced packaging, materials, and infrastructure, with the government urged to shoulder a meaningful share to reduce risk for private investors. The big picture here is strategic: semiconductors are now treated like critical infrastructure, and countries want more control over the supply of the components that power everything from phones to defense systems. AI memory boom reshapes pricing On markets and manufacturing, the memory-chip industry just had a striking moment: Micron and SK Hynix surged to trillion-dollar valuations within days of each other, joining Samsung—meaning all three major memory makers briefly hit the milestone at once. What changed is AI. High-bandwidth memory, used in AI-focused graphics processors and accelerators, has turned a business once known for brutal oversupply cycles into a high-growth segment. The flip side is that as companies prioritize AI memory, supply of more traditional chips for everyday electronics can tighten. Industry leaders are warning demand could run ahead of supply for years, which raises the odds that consumers eventually feel it in the price of devices like PCs and smartphones. Nvidia bets big on photonics Nvidia is also placing a major bet on what comes next inside the data center: photonics, or using light to move data instead of electricity. Since March, Nvidia has committed at least six and a half billion dollars to companies building optical components and supply chains, arguing that copper connections are increasingly limited by power draw and heat as AI systems scale up. The company’s view is that future “AI factory” systems will need far more optical connectivity than the world can currently produce. The catch is manufacturing: making complex optical assemblies reliably and at scale is hard, and broader adoption could still be a couple of years away. But the direction is clear—if AI keeps growing, the plumbing that connects chips will matter almost as much as the chips themselves. AI tools help disabled musicians Finally, a story at the intersection of AI and accessibility: London singer-songwriter Samuel Smith, who was diagnosed with Parkinson’s disease in 2020, says generative AI music tools helped him finish his second album after tremors and fatigue made it difficult to play guitar. His approach wasn’t about dropping AI audio into the final tracks—he used tools to turn hummed ideas into rough demo arrangements that session musicians could then bring to life. It’s a reminder that while the industry argues over training data and copyright, there’s another angle: assistive creativity. For artists with illness or disability, these tools can act less like a shortcut and more like a bridge back into collaboration and production. Subscribe to edition specific feeds: - Space news * Apple Podcast English [https://apple.co/4cLLrdt] * Spotify English [https://spoti.fi/4jN8Dui] * RSS English [https://bit.ly/the_automated_daily_space] Spanish [https://theautomateddaily.com/space_es/feed.xml] French [https://theautomateddaily.com/space_fr/feed.xml] - Top news * Apple Podcast English [https://apple.co/3PTvdUF] Spanish [https://apple.co/3ECCMgk] French [https://apple.co/4hmcxbB] * Spotify English [https://spoti.fi/3ZYXAW2] Spanish [https://spoti.fi/414h4JD] French [https://spoti.fi/3Di0jDe] * RSS English [https://bit.ly/the_automated_daily_news] Spanish [https://bit.ly/the_automated_daily_news_es] French [https://bit.ly/the_automated_daily_news_fr] - Tech news * Apple Podcast English [https://apple.co/3RYWbg4] Spanish [https://apple.co/4i0WqRM] French [https://apple.co/4bEAXMm] * Spotify English [https://spoti.fi/3S089pG] Spanish [https://spoti.fi/3EE2Fwv] Spanish [https://spoti.fi/3DlObRE] * RSS English [https://bit.ly/the_automated_daily_tech] Spanish [https://bit.ly/the_automated_daily_tech_es] French [https://bit.ly/the_automated_daily_tech_fr] - Hacker news * Apple Podcast English [https://apple.co/48QWyzj] Spanish [https://apple.co/4ke9jtE] French [https://apple.co/41E1qFd] * Spotify English [https://spoti.fi/45zD1kf] Spanish [https://spoti.fi/4hF8h81] French [https://spoti.fi/3QY26Ak] * RSS English [https://bit.ly/the_automated_daily_hacker_news] Spanish [https://bit.ly/the_automated_daily_hacker_news_es] French [https://bit.ly/the_automated_daily_hacker_news_fr] - AI news * Apple Podcast English [https://apple.co/3M6Tg1o] Spanish [https://apple.co/4315L7Y] French [https://apple.co/3DkZbPb] * Spotify English [https://spoti.fi/3tzOfrz] Spanish [https://spoti.fi/416m40q] French [https://spoti.fi/41HuJGW] * RSS English [https://bit.ly/the_automated_daily_hackernews_ai] Spanish [https://bit.ly/the_automated_daily_hackernews_es_ai] French [https://bit.ly/the_automated_daily_hackernews_fr_ai] Visit our website at https://theautomateddaily.com/ [ https://theautomateddaily.com/] Send feedback to feedback@theautomateddaily.com Youtube [https://www.youtube.com/@TheAutomatedDaily] LinkedIn [https://www.linkedin.com/in/the-automated-daily/] X (Twitter) [https://x.com/automated_daily]
2 meses por 1 €
Después 4,99 € / mes · Cancela cuando quieras
- Podcasts exclusivos
- 20 horas de audiolibros / mes
- Podcast gratuitos
Todos los episodios
100 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de The Automated Daily - Top News Edition!